Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | COX6A2 |
| Upstream (Parents) |
|---|
| (<<) ACTC1 → COX6A2 |
| (<<) ADAM12 → COX6A2 |
| (<<) ENO3 → COX6A2 |
| (<<) GLTPD1 → COX6A2 |
| (<<) LIPG → COX6A2 |
| (<<) MYLK → COX6A2 |
| (<<) NRG1 → COX6A2 |
| (<<) PODXL → COX6A2 |
| (<<) TPM1 → COX6A2 |
| (<<) TPM2 → COX6A2 |
| Downstream (Children) |
|---|
| COX6A2 → ACTN3 (>>) |
| COX6A2 → BMPR2 (>>) |
| COX6A2 → CABC1 (>>) |
| COX6A2 → CAV3 (>>) |
| COX6A2 → CHST7 (>>) |
| COX6A2 → FKSG2 (>>) |
| COX6A2 → GNG12 (>>) |
| COX6A2 → HDAC4 (>>) |
| COX6A2 → ITGB7 (>>) |
| COX6A2 → KRT14 (>>) |
| COX6A2 → MMP28 (>>) |
| COX6A2 → MYL3 (>>) |
| COX6A2 → PHGDH (>>) |
| COX6A2 → ROR2 (>>) |
| COX6A2 → RXRG (>>) |
| COX6A2 → SMURF1 (>>) |
| COX6A2 → TPM3 (>>) |
